The proposed studies will evaluate the mechanisms by which dehydroepiandrosterone (DHEA) and its reduced metabolite (5-ene-androstene- 3beta,17beta-diol or ADIOL) alter the metabolic activation and early steps in the promotion phase of chemical carcinogenesis and toxicity. Since feeding of these compounds blocks chemical carcinogenesis and a number of deleterious pathophysiological states, we will evaluate the effect of these androgens on induction of enzymes commonly involved in the metabolic activation or detoxification of chemical carcinogens and toxicants to establish whether they either directly inhibit the action of these enzymes or affect induction of detoxification enzymes to ameliorate their effects. 1. The goal of aim 1 is to characterize the enzymes involved in carcinogen and drug metabolism and the biochemical mechanism by which they are induced or suppressed by these steroid chemopreventive agents. After we identify and characterize the form(s) of xenobiotic metabolizing enzymes induced by DHEA, we will study of the mechanism(s) of induction (transcription, translation, stabilization) of these proteins. The structure-function relationship of induction of these enzymes will be established to elucidate its putative receptor. 2. The goal of Aim 2 is to establish whether there are alterations of other processes involved in subsequent phases of chemical carcinogenesis or toxicity with DHEA-feeding. Activities of key processes in carcinogenesis will be monitored to establish any effect of DHEA and ADIOL administration. Since chemical carcinogenesis by PAH is thought to involve the induction of cytochrome P450IA1, we will establish whether DHEA or ADIOL inhibit the induction of PAH-inducible enzymes. Any role of DHEA or ADIOL in altering normal hormone-mediated expression of a limited number of P450s (IIB1, IIIA1, IIC11) will be studied and the modulating effect of other hormones on the expression of proteins (P450IVA1, NADPH-cytochrome P450 oxidoreductase, malic enzyme) with DHEA will be tested. 3. The goal of Aim 3 is to establish whether these chemopreventive agents simultaneously cause increases in hydrogen peroxide production and decreases in carcinogen metabolism in isolated rodent hepatocytes. The effects of DHEA and ADIOL on the enzyme activities associated with carcinogen activation or detoxification in cultured rat hepatocytes will be studied to elucidate any direct or indirect inhibitory actions of these androgens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA043839-07
Application #
3186229
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1986-03-01
Project End
1995-11-30
Budget Start
1992-12-01
Budget End
1993-11-30
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Louisville
Department
Type
Schools of Medicine
DUNS #
City
Louisville
State
KY
Country
United States
Zip Code
40292
Singleton, D W; Lei, X D; Webb, S J et al. (1999) Cytochrome P-450 mRNAs are modulated by dehydroepiandrosterone, nafenopin, and triiodothyronine. Drug Metab Dispos 27:193-200
Lubet, R A; Gordon, G B; Prough, R A et al. (1998) Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations. Cancer Res 58:921-6
Song, W; Chen, J; Dean, W L et al. (1998) Purification and characterization of hamster liver microsomal 7alpha-hydroxycholesterol dehydrogenase. Similarity to type I 11beta-hydroxysteroid dehydrogenase. J Biol Chem 273:16223-8
Song, W; Pierce Jr, W M; Saeki, Y et al. (1996) Endogenous 7-oxocholesterol is an enzymatic product: characterization of 7 alpha-hydroxycholesterol dehydrogenase activity of hamster liver microsomes. Arch Biochem Biophys 328:272-82
Webb, S J; Xiao, G H; Geoghegan, T E et al. (1996) Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone. Mol Pharmacol 49:276-87
Prough, R A; Webb, S J; Wu, H Q et al. (1994) Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats. Cancer Res 54:2878-86
Gettings, S D; Brewer, C B; Pierce Jr, W M et al. (1990) Enhanced decomposition of oxyferrous cytochrome P450CIA1 (P450cam) by the chemopreventive agent 3-t-butyl-4-hydroxyanisole. Arch Biochem Biophys 276:500-9
Tweedie, D J; Prough, R A; Burke, M D (1988) Effects of induction on the metabolism and cytochrome P-450 binding of harman and other beta-carbolines. Xenobiotica 18:785-96
Tweedie, D J; Burke, M D (1987) Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrene-treated mice. Identification and quantitation of two novel harmine metabolites. Drug Metab Dispos 15:74-81